Compared to Estimates, CRH (CRH) Q2 Earnings: A Look at Key Metrics

07.08.25 01:30 Uhr

Werte in diesem Artikel
Aktien

94,50 EUR -1,00 EUR -1,05%

71,00 EUR 3,50 EUR 5,19%

Indizes

570,1 PKT 0,8 PKT 0,14%

5.828,2 PKT -10,0 PKT -0,17%

CRH (CRH) reported $10.21 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 5.7%. EPS of $1.94 for the same period compares to $1.85 a year ago.The reported revenue represents a surprise of -1.19% over the Zacks Consensus Estimate of $10.33 billion. With the consensus EPS estimate being $1.84, the EPS surprise was +5.43%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how CRH performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Americas Materials Solutions: $4.51 billion versus the three-analyst average estimate of $4.7 billion.Revenue- International Solutions: $3.54 billion versus $3.44 billion estimated by three analysts on average.Revenue- Americas Building Solutions: $2.16 billion versus the three-analyst average estimate of $2.17 billion.View all Key Company Metrics for CRH here>>>Shares of CRH have returned +3.5% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CRH PLC (CRH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf CRH

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CRH

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu CRH plc

Wer­bung

Analysen zu CRH plc

DatumRatingAnalyst
06.10.2023CRH BuyJefferies & Company Inc.
27.09.2023CRH BuyJefferies & Company Inc.
26.09.2023CRH BuyUBS AG
13.09.2023CRH OverweightJP Morgan Chase & Co.
12.09.2023CRH BuyJefferies & Company Inc.
DatumRatingAnalyst
06.10.2023CRH BuyJefferies & Company Inc.
27.09.2023CRH BuyJefferies & Company Inc.
26.09.2023CRH BuyUBS AG
13.09.2023CRH OverweightJP Morgan Chase & Co.
12.09.2023CRH BuyJefferies & Company Inc.
DatumRatingAnalyst
13.07.2022CRH Equal-weightMorgan Stanley
15.03.2022CRH Equal-weightMorgan Stanley
04.03.2022CRH Equal WeightBarclays Capital
19.01.2022CRH Equal WeightBarclays Capital
17.12.2021CRH HoldKepler Cheuvreux
DatumRatingAnalyst
19.06.2023CRH SellGoldman Sachs Group Inc.
22.05.2023CRH SellGoldman Sachs Group Inc.
26.04.2023CRH SellGoldman Sachs Group Inc.
02.03.2023CRH SellGoldman Sachs Group Inc.
22.11.2022CRH SellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CRH plc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen